XWELL (NASDAQ:XWEL) Stock Price Down 4.5% – Time to Sell?

XWELL, Inc. (NASDAQ:XWEL) shares dropped 4.5% during trading on Monday . The company traded as low as $0.2706 and last traded at $0.3906. Approximately 6,070,875 shares changed hands during trading, an increase of 439% from the average daily volume of 1,126,655 shares. The stock had previously closed at $0.4090.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of XWELL in a research note on Wednesday, January 21st. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company presently has a consensus rating of “Sell”.

XWELL Stock Performance

The firm has a market cap of $2.25 million, a price-to-earnings ratio of -0.12 and a beta of 1.51. The business’s 50-day moving average is $0.53 and its 200-day moving average is $0.84.

XWELL (NASDAQ:XWEL) last issued its quarterly earnings data on Friday, November 14th. The company reported ($0.26) earnings per share for the quarter. The firm had revenue of $7.35 million for the quarter. XWELL had a negative return on equity of 352.37% and a negative net margin of 51.85%.

About XWELL

XWELL, Inc provides health and wellness services in airport and off airport marketplaces in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler's spa services, including massage, nail, and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels.